ASX:CSLBiotechs
CSL (ASX:CSL) Shares Could Be 31.5% Undervalued Before Full Year Results
CSL (ASX:CSL) is back in focus after a sharp share price rebound, with investors weighing the upcoming August 18 full-year results and dividend announcement against recent guidance cuts and asset impairments.
See our latest analysis for CSL.
The recent rebound has lifted CSL’s 7 day share price return to 6.8% and its 30 day share price return to 8.5%. However, its year to date share price return is still down 38.2% and the 1 year total shareholder return has declined 54.5%. This indicates...